GrowingStockReport.com

Akamai Technologies, Inc. (NASDAQ:AKAM) and Pharmacyclics Inc. (NASDAQ:PCYC) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 02/25/2014 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Akamai Technologies, Inc. (NASDAQ:AKAM) and Pharmacyclics Inc. (NASDAQ:PCYC).

Akamai Technologies, Inc. (NASDAQ:AKAM) a company that provides content delivery and cloud infrastructure services for accelerating and improving the delivery of content and applications over the Internet in the United States and internationally is currently up (+1.52%) on 1,995,627 shares traded. Akamai Technologies, Inc. (NASDAQ:AKAM) is currently up (+93.5%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Akamai Technologies, Inc. (NASDAQ:AKAM)

Pharmacyclics Inc. (NASDAQ:PCYC) a clinical-stage biopharmaceutical company that focuses on the development and commercialization of small-molecule drugs for the treatment of cancer and immune mediated diseases is currently up (+0.61%) on 870,931 shares traded after Pharmacyclics price target was raised to $191 from $163 at JMP Securities. Pharmacyclics Inc. (NASDAQ:PCYC) is currently up (+114.91%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Pharmacyclics Inc. (NASDAQ:PCYC)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com